This trial is active, not recruiting.

Condition lipodystrophy
Treatment autologous transplantation of liposuction material enriched with adipose-derived stem cells
Phase phase 1
Sponsor Irmandade Santa Casa de Misericórdia de Porto Alegre
Start date October 2007
End date August 2011
Trial size 5 participants
Trial identifier NCT00715546, ISCMPA 1642/07


The aim of this study is to determine the safety of the autologous transplantation of adipose-derived stem cells in the treatment of lipodystrophies.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Endpoint classification safety study
Intervention model single group assignment
Masking open label
Primary purpose treatment

Primary Outcomes

Clinical evaluation of the transplanted area.
time frame: one year

Secondary Outcomes

Presence of neovascularization, adipose transplantation reabsorption, tissue viability
time frame: one year

Eligibility Criteria

Male or female participants at least 20 years old.

Inclusion Criteria: - lipodystrophies with necessity of fat grafting - accept to participate of the study Exclusion Criteria: - HIV infection - Metastatic malignancy - Body mass index < 20 kg/m² - Other severe systemic disease

Additional Information

Official title Phase 1 Study of Autologous-Derived Stem Cell Transplantation in Patients With Lipodystrophy
Principal investigator Eduardo M. Chem, MD
Trial information was received from ClinicalTrials.gov and was last updated in June 2011.
Information provided to ClinicalTrials.gov by Irmandade Santa Casa de Misericórdia de Porto Alegre.